1
|
Galbiati A, Sforza M, Leitner C, Filice A, Manconi M, Ferini Strambi L, Castronovo V. 0526 Objective Total Sleep Duration Do Not Predicting the Effectiveness of Cognitive-Behavioral Therapy for Insomnia (CBT-I). Sleep 2020. [DOI: 10.1093/sleep/zsaa056.523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Several studies investigated the role of objective sleep markers, in particular of Total Sleep Time (TST) in identifying different subtypes of Insomnia Disorder (ID) and in evaluating the efficacy of treatments. Based on objective TST two phenotypes of ID are usually distinguished in the literature: normal sleepers (objective sleep duration ≥ 6 hours) and short sleepers (objective sleep duration < 6 hours). Aim of our study was to evaluate in normal and short sleepers (objective sleep duration was assessed by both Polysomnography and Actigraphy) possible different response to Cognitive-Behavioral Therapy for Insomnia (CBT-I).
Methods
53 ID patients (females = 50.9%; mean age = 56.53±11.43) were divided into “Short Sleep duration” and “Normal Sleep duration” groups. All patients underwent 7-sessions group CBT-I. Main clinical outcome was Insomnia Severity Index questionnaire (ISI); secondary outcomes were Sleep Efficacy (SE), Sleep Latency (SL), Wake After Sleep Onset (WASO), Number of Awakenings (N°awk) according to sleep diaries.
Results
All ID patients showed significant improvements after treatment for all clinical outcomes. Non-significant effects of CBT-I between “Short Sleep duration” and “Normal Sleep duration” measured by patients were found in terms of ISI, SE, SL, WASO and N°awk, neither using Polysomnography nor Actigraphy. Furthermore, no accordance between these two objective measurements was found for the identification of the two subgroups.
Conclusion
Our findings suggest that the use of objective TST (both by Actigraphy and Polysomnography) is not a consistent predictor for CBT-I effectiveness. Moreover, only a small percentage of patients were classified as short or normal sleepers according both to Polysomnography and Actigraphy. These findings underline the instability and poor reliability of using objective TST in subtyping insomniacs.
Support
No
Collapse
Affiliation(s)
- A Galbiati
- Sleep Disorder Center, Vita-Salute San Raffaele University, Milan, ITALY
| | - M Sforza
- Sleep Disorder Center, Vita-Salute San Raffaele University, Milan, ITALY
| | - C Leitner
- Sleep Disorder Center, Vita-Salute San Raffaele University, Milan, ITALY
| | - A Filice
- Sleep Disorder Center, Vita-Salute San Raffaele University, Milan, ITALY
| | - M Manconi
- Sleep Center, Neurocenter of Southern Switzerland, Regional Hospital of Lugano, Lugano, SWITZERLAND
| | - L Ferini Strambi
- Sleep Disorder Center, Vita-Salute San Raffaele University, Milan, ITALY
| | - V Castronovo
- Sleep Disorder Center, San Raffaele Hospital, Milan, ITALY
| |
Collapse
|
2
|
Veltroni A, Cosaro E, Spada F, Fazio N, Faggiano A, Colao A, Pusceddu S, Zatelli MC, Campana D, Piovesan A, Pia A, Grossrubatscher EM, Filice A, Bianchi A, Razzore P, Toaiari M, Cingarlini S, Landoni L, Micciolo R, Davì MV. Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study. Eur J Endocrinol 2020; 182:439-446. [PMID: 32061159 DOI: 10.1530/eje-19-0989] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/09/2019] [Accepted: 02/12/2020] [Indexed: 11/08/2022]
Abstract
INTRODUCTION Management of malignant insulinomas is challenging due to the need to control both hypoglycaemic syndrome and tumor growth. Literature data is limited to small series. AIM OF THE STUDY To analyze clinico-pathological characteristics, treatments and prognosis of patients with malignant insulinoma. MATERIALS AND METHODS Multicenter retrospective study on 31 patients (male: 61.3%) diagnosed between 1988 and 2017. RESULTS The mean age at diagnosis was 48 years. The mean NET diameter was 41 ± 31 mm, and 70.8% of NETs were G2. Metastases were widespread in 38.7%, hepatic in 41.9% and only lymph nodal in 19.4%. In 16.1% of the cases, the hypoglycaemic syndrome occurred after 46 ± 35 months from the diagnosis of originally non-functioning NET, whereas in 83.9% of the cases it led to the diagnosis of NET, of which 42.3% with a mean diagnostic delay of 32.7 ± 39.8 months. Surgical treatment was performed in 67.7% of the cases. The 5-year survival rate was 62%. Overall survival was significantly higher in patients with Ki-67 ≤10% (P = 0.03), insulin level <60 µU/mL (P = 0.015) and in patients who underwent surgery (P = 0.006). Peptide Receptor Radionuclide Therapy (PRRT) was performed in 45.1%, with syndrome control in 93% of patients. CONCLUSIONS Our study includes the largest series of patients with malignant insulinoma reported to date. The hypoglycaemic syndrome may occur after years in initially non-functioning NETs or be misunderstood with delayed diagnosis of NETs. Surgical treatment and Ki67 ≤10% are prognostic factors associated with better survival. PPRT proved to be effective in the control of hypoglycaemia in majority of cases.
Collapse
Affiliation(s)
- A Veltroni
- Section of Endocrinology, Department of Medicine, ENETS Center of Excellence, Verona University, Verona, Italy
| | - E Cosaro
- Section of Endocrinology, Department of Medicine, ENETS Center of Excellence, Verona University, Verona, Italy
| | - F Spada
- Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, ENETS Center of Excellence, European Institute of Oncology, IEO, IRCCS, Milan, Italy
| | - N Fazio
- Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, ENETS Center of Excellence, European Institute of Oncology, IEO, IRCCS, Milan, Italy
| | - A Faggiano
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | - A Colao
- Endocrinology Division, Department of Clinical Medicine and Surgery, ENETS Center of Excellence, University of Naples Federico II, Naples, Italy
| | - S Pusceddu
- Fondazione IRCCS Istituto Nazionale Tumori, ENETS Center of Excellence, Milan, Italy
| | - M C Zatelli
- Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - D Campana
- Department of Medical and Surgical Sciences, ENETS Center of Excellence, University of Bologna, Bologna, Italy
| | - A Piovesan
- Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - A Pia
- Internal Medicine, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy
| | - E M Grossrubatscher
- S.C. Endocrinologia ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - A Filice
- Nuclear Medicine Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy
| | - A Bianchi
- Pituitary Unit, Fondazione Policlinico A. Gemelli IRCCS, Catholic University, ENETS Center of Excellence, School of Medicine, Rome, Italy
| | | | - M Toaiari
- Pederzoli Hospital, Peschiera del Garda, Italy
| | - S Cingarlini
- Oncology, ENETS Center of Excellence, University of Verona, Verona, Italy
| | - L Landoni
- Pancreatic Surgery, ENETS Center of Excellence, University of Verona, Verona, Italy
| | - R Micciolo
- Department of Psychology and Cognitive Sciences, University of Trento, Trento, Italy
| | - M V Davì
- Section of Endocrinology, Department of Medicine, ENETS Center of Excellence, Verona University, Verona, Italy
| |
Collapse
|
3
|
Lococo F, Rena O, Torricelli F, Filice A, Di Stefano T, Rapicetta C, Coruzzi C, Boldorini R, Ciarrocchi A, Versari A, Paci M. P1.06-10 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Diagnostic/Prognostic Performance and Correlation with Pathological Results. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.997] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
4
|
Rea A, Caldarola GG, Sandomenico C, Colangelo M, Filice A, Mastroianni CM, Biamonte R, Palazzo S. De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report. Tumori 2018; 88:A21-4. [PMID: 12400992 DOI: 10.1177/030089160208800473] [Citation(s) in RCA: 67] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Summary Treatment of patients affected by metastatic gastric cancer with low performance status (PS) is a very hard choice. It is mandatory to define a very well-tolerated schedule to be employed in these subgroup of patients. Patients and Methods From June 1999 to December 2001, 21 patients (pts) affected by metastatic gastric cancer with low performance status (≥2 ECOG) were treated with bimonthly “de Gramont” schedule. Treatment was planned to perform 6 courses of chemotherapy for each patient plus other 2-4 if a response had been documented. Results A total of 161 courses of de Gramont schedule was administered to the 21 pts enrolled. We observed 8 PD (38%), 8 SD (38%), 5 objective responses (24% – 2 MR, 3 PR). Duration of objective responses (OR) was 5 months, 3 months for 3 PRs and 2 and 1 months for two MRs respectively. At time of observation (June 2002) median overall survival (OS) was 14 months, median survival from the starting de Gramont schedule was 8 months. Toxicity was very mild: grade 3 leukopenia in 1 pt, grade 1-2 anemia and piastrinopenia in 3 pts, grade 1-2 nausea vomiting in 5 pts, grade 1 diarrhea in 4 pts, grade 3 mucositis in 2 pts. No other side effect was renowned. PS ameliorated in 12 (57%) pts, even if a major response was not noted. Conclusions de Gramont schedule can be safely and effectively employed in metastatic gastric cancer pts with very low performance status.
Collapse
Affiliation(s)
- Antonio Rea
- UO Oncologia, PO Mariano Santo, Azienda Ospedaliera di Cosenza
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R. Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. Endocrine 2018; 59:90-101. [PMID: 29110129 DOI: 10.1007/s12020-017-1455-6] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2017] [Accepted: 10/10/2017] [Indexed: 12/21/2022]
Abstract
PURPOSE AND PATIENTS The M.O.S.CA.TI. (Metastases of the Skeleton from CArcinoma of the ThyroId) is a multicenter, retrospective study investigating the real-life outcome and management of bone metastases (BM) in 143 patients (63 M, 80 F; median age 64 years, range 11-87) with differentiated thyroid carcinoma (DTC). RESULTS Radio-active iodine (RAI) treatment was performed in 131 patients (91.6%), surgical approach and/or external radiotherapy in 68 patients (47.6%), and anti-resorptive bone-active drugs in 32 patients (22.4%; in 31 zoledronate and in one denosumab). At the start of treatment, 24 patients (75.0%) receiving anti-resorptive bone-active drugs had at least one clinical skeletal-related event (SRE) (p < 0.001). One or more clinical SREs (pathological fractures and/or malignant hypercalcemia and/or spinal cord compression) developed in 53 patients (37.1%). Development of SREs was significantly associated with metachronous BM (hazard ratio (HR) 2.04; p = 0.04), localization of BM to cervical spine (HR 3.89; p = 0.01), and lack of avid RAI uptake (HR 2.66; p = 0.02). Thirty-nine patients (27.3%) died in correlation with development of SREs (HR 6.97; p = 0.006) and localization of BM to the hip (HR 3.86; p = 0.02). Moreover, overall mortality was significantly decreased by RAI therapy (HR 0.10; p = 0.02), whereas no significant effects were induced by bone-active drugs (p = 0.36), external radiotherapy (p = 0.54), and surgery (p = 0.43) of BM. CONCLUSIONS SREs are very frequent in BM from DTC and they impact patient survival. In the real life, the use of bone-active drugs is currently limited to zoledronate in patients with pre-existing SREs. In this clinical setting, RAI therapy, but not zoledronate, decreased mortality.
Collapse
Affiliation(s)
- G Mazziotti
- Endocrine Unit, ASST Carlo Poma, Mantua, Italy
| | - A M Formenti
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy
| | - M B Panarotto
- Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy
- Nuclear Medicine, University of Brescia, Brescia, Italy
| | - E Arvat
- Oncological Endocrinology, University of Turin, Torino, Italy
| | - A Chiti
- Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy
- Humanitas University, Milan, Italy
| | - A Cuocolo
- Nuclear Medicine, University of Naples Federico II, Napoli, Italy
| | - M E Dottorini
- Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy
| | - C Durante
- Internal Medicine, University Sapienza of Rome, Roma, Italy
| | - L Agate
- Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - S Filetti
- Internal Medicine, University Sapienza of Rome, Roma, Italy
| | - F Felicetti
- Oncological Endocrinology, University of Turin, Torino, Italy
| | - A Filice
- Nuclear Medicine, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Reggio Emilia, Italy
| | - L Pace
- Department of Medicine and Surgery, University of Salerno, Fisciano, Italy
| | - T Pellegrino
- Institute of Biostructure and Bioimaging of the National Research Council of Italy-CNR, Naples, Italy
| | - M Rodari
- Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy
| | - M Salvatori
- Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy
| | - C Tranfaglia
- Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy
| | - A Versari
- Nuclear Medicine, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Reggio Emilia, Italy
| | - D Viola
- Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - S Frara
- San Raffaele Vita-Salute University, Milan, Italy
| | - A Berruti
- Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy
| | - A Giustina
- San Raffaele Vita-Salute University, Milan, Italy.
| | - R Giubbini
- Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy
- Nuclear Medicine, University of Brescia, Brescia, Italy
| |
Collapse
|
6
|
Turano S, Manfredi C, Conforti S, Biamonte R, Rovito A, Filice A, Minardi S, Mastroianni C, Liguori V, De Simone R, Piattelli A, Iuvaro M, Toretti A, Palazzo S. The value of trabectedin in the treatment of soft tissue sarcoma: a monoinstitutional retrospective real-life study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx427.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
7
|
Lococo F, Rapicetta C, Formisano D, Galeone C, Filice A, Fioroni F, Bellafiore S, Ricchetti T, Taddei S, Paci M. F-03718-F FDG PET/CT SCAN IN SOLID-TYPE STAGE-I PULMONARY ADENOCARCINOMAS: WHAT CAUSES FALSE-NEGATIVE CASES? Interact Cardiovasc Thorac Surg 2016. [DOI: 10.1093/icvts/ivw260.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
8
|
Piattelli A, Biamonte R, Turano S, Manfredi C, Mastroianni C, De Simone R, Minardi S, Bartucci M, Marafioti L, Conforti S, Filice A, Liguori V, Loizzo M, Rovito A, Iuvaro M, Toretti A, Colistra E, Palazzo S. An Etiquette-Based Medicine Decalogue on the Professional style in the Multidisciplinary Unit (UVM) of Cosenza Hospital Oncology Department. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw342.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Palazzo S, Filice A, Mastroianni C, Biamonte R, Conforti S, Liguori V, Turano S, De Simone R, Rovito A, Manfredi C, Minardi S, Vilardo E, Loizzo M, Oriolo C. [Value-based cancer care. From traditional evidence-based decision making to balanced decision making within frameworks of shared values]. Recenti Prog Med 2016; 107:175-80. [PMID: 27093326 DOI: 10.1701/2218.23926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Clinical decision making in oncology is based so far on the evidence of efficacy from high-quality clinical research. Data collection and analysis from experimental studies provide valuable insight into response rates and progression-free or overall survival. Data processing generates valuable information for medical professionals involved in cancer patient care, enabling them to make objective and unbiased choices. The increased attention of many scientific associations toward a more rational resource consumption in clinical decision making is mirrored in the Choosing Wisely campaign against the overuse or misuse of exams and procedures of little or no benefit for the patient. This cultural movement has been actively promoting care solutions based on the concept of "value". As a result, the value-based decision-making process for cancer care should not be dissociated from economic sustainability and from ethics of the affordability, also given the growing average cost of the most recent cancer drugs. In support of this orientation, the National Comprehensive Cancer Network (NCCN) has developed innovative and "complex" guidelines based on values, defined as "evidence blocks", with the aim of assisting the medical community in making overall sustainable choices.
Collapse
Affiliation(s)
| | - Aldo Filice
- UOC di Oncologia Medica, PO dell'Annunziata, Cosenza
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Rapicetta C, Ragazzi M, Filice A, Treglia G, Sgarbi G, Cesario A, Lococo F. A rare case of schwannomatosis incidentally detected by ¹⁸F-FDG PET/CT during metabolic evaluation of a chest wall tumor. Rev Esp Med Nucl Imagen Mol 2014; 34:150-2. [PMID: 25459196 DOI: 10.1016/j.remn.2014.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2014] [Revised: 10/01/2014] [Accepted: 10/04/2014] [Indexed: 11/19/2022]
Affiliation(s)
- C Rapicetta
- Unit of Thoracic Surgery, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - M Ragazzi
- Unit of Pathology, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - A Filice
- Department of Nuclear Medicine, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - G Treglia
- Department of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
| | - G Sgarbi
- Unit of Thoracic Surgery, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - A Cesario
- Scientific Direction, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - F Lococo
- Unit of Thoracic Surgery, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
| |
Collapse
|
11
|
Grassi E, Fioroni F, Ferri V, Mezzenga E, Sarti MA, Paulus T, Lanconelli N, Filice A, Versari A, Iori M. Quantitative comparison between the commercial software STRATOS(®) by Philips and a homemade software for voxel-dosimetry in radiopeptide therapy. Phys Med 2014; 31:72-9. [PMID: 25457430 DOI: 10.1016/j.ejmp.2014.10.002] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2013] [Revised: 10/02/2014] [Accepted: 10/05/2014] [Indexed: 10/24/2022] Open
Abstract
BACKGROUND Targeted radionuclide therapy is a rapidly growing modality. A few commercial treatment planning systems are entering the market. However, some in-house systems are currently developed for a more flexible and customized dosimetry calculation at voxel-level. For this purpose, we developed a novel software, VoxelMed, and performed a comparison with the software STRATOS. METHODS The validation of both of them was undertaken using radioactive phantoms with different volume inserts. A cohort of 10 patients was also studied after a therapeutic administration of (177)Lu-labelled radiopeptides. The activity, number of disintegrations, absorbed dose and dose-volume histogram (DVH) were calculated for the phantoms and the kidneys in patients, which were the main critical organs at risk in this study. RESULTS In phantoms the absorbed doses computed with VoxelMed and STRATOS agree within 5%. In patients at the voxel-level the absorbed dose to kidneys (VoxelMed: mean 0.66 Gy/GBq) showed a limited difference of 5%, but with a remarkable range (-40%, +60%) between the two software packages. Voxel-dosimetry allows to estimate the dose non-homogeneities in volumes, which may be evaluated through DVHs. CONCLUSION This study demonstrates that a fully 3D voxel-dosimetry with multiple SPECT images is feasible by using home-made or commercial software package and absorbed dose results obtained are similar. The main difference between the studied tools was observed in the activity integration method (effective vs physical half-time to time activity curve tail). We believe that an effective half-time integration method produces a more accurate approximation of clinical uptake and resultant dosimetry.
Collapse
Affiliation(s)
- E Grassi
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy.
| | - F Fioroni
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - V Ferri
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - E Mezzenga
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - M A Sarti
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - T Paulus
- Philips Technologie GmbH Innovative Technologies, Pauwelsstr. 17, 52074 Aachen, Germany
| | - N Lanconelli
- Dept. of Physics, University of Bologna, I-40126 Bologna, Italy
| | - A Filice
- Nuclear Medicine Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - A Versari
- Nuclear Medicine Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - M Iori
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| |
Collapse
|
12
|
Lococo F, Cafarotti S, Filice A, Bertagna F, Treglia G. A false positive finding on the PET of somatostatin receptor due to a chondromyxoid fibroma. Rev Esp Med Nucl Imagen Mol 2014. [DOI: 10.1016/j.remnie.2014.06.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
13
|
Lococo F, Rapicetta C, Ricchetti T, Cavazza A, Filice A, Treglia G, Tenconi S, Paci M, Sgarbi G. Diagnostic pitfalls in the preoperative 18F-FDG PET/CT evaluation of a case of giant malignant solitary fibrous tumor of the pleura. Rev Esp Med Nucl Imagen Mol 2014. [DOI: 10.1016/j.remnie.2014.02.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
14
|
Lococo F, Cafarotti S, Filice A, Bertagna F, Treglia G. A false positive finding on the PET of somatostatin receptor due to a chondromyxoid fibroma. Rev Esp Med Nucl Imagen Mol 2013; 33:245-6. [PMID: 24140025 DOI: 10.1016/j.remn.2013.09.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2013] [Revised: 09/02/2013] [Accepted: 09/03/2013] [Indexed: 11/19/2022]
Affiliation(s)
- F Lococo
- Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
| | - S Cafarotti
- Unit of Thoracic Surgery, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
| | - A Filice
- Department of Nuclear Medicine, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - F Bertagna
- Chair of Nuclear Medicine, University of Brescia and Spedali Civili di Brescia, Brescia, Italy
| | - G Treglia
- Department of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
| |
Collapse
|
15
|
Lococo F, Rapicetta C, Ricchetti T, Cavazza A, Filice A, Treglia G, Tenconi S, Paci M, Sgarbi G. Diagnostic pitfalls in the preoperative 18F-FDG PET/CT evaluation of a case of giant malignant solitary fibrous tumor of the pleura. Rev Esp Med Nucl Imagen Mol 2013; 33:109-11. [PMID: 24079956 DOI: 10.1016/j.remn.2013.07.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2013] [Revised: 07/21/2013] [Accepted: 07/24/2013] [Indexed: 11/26/2022]
Abstract
Solitary fibrous tumor of the pleura (SFTP) is an uncommon entity, generally with an indolent behavior. Nevertheless, some malignant forms have been rarely reported. These, often have an aggressive biological behavior with pathological findings of invasiveness. The preoperative diagnosis and evaluation of the grade of malignancy are extremely challenging. Herein we report a case of a 64-year-old man who presented with a left giant intra-thoracic mass imaged with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG/PET-CT) and sampled via fine-needle aspiration biopsy (FNAB). Imaging and FNAB findings showed suspicion of a benign form of SFTP. Surgical radical resection of the giant mass was performed. The definitive histological diagnosis showed a malignant SFTP. Based on this report, we take the opportunity to briefly discuss the insidious pitfalls concerning the radiological and (18)F-FDG/PET-CT features as well as cyto/histological findings in the pre-operative diagnostic work-up examination of this rare entity.
Collapse
Affiliation(s)
- F Lococo
- Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
| | - C Rapicetta
- Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - T Ricchetti
- Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - A Cavazza
- Division of Pathology, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - A Filice
- Department of Nuclear Medicine, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - G Treglia
- Department of Nuclear Medicine, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
| | - S Tenconi
- Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - M Paci
- Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| | - G Sgarbi
- Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
| |
Collapse
|
16
|
Mastroianni CM, Viscomi C, Ceniti S, De Simone R, Filice A, Gadaleta Caldarola G, Infusino S, Manfredi C, Rea A, Sandomenico C, Turano S, Serranò F, Condemi G, Cortese C, Prantera T, Palazzo S. Preferences of patients with advanced colorectal cancer for treatment with oral or intravenous chemotherapy. Patient 2012; 1:181-7. [PMID: 22272925 DOI: 10.2165/1312067-200801030-00005] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
BACKGROUND In recent years, patient-reported outcomes such as health-related quality of life have become important areas of clinician focus in general cancer management. Patients' preferences for, and/or satisfaction with, oral versus intravenous (IV) chemotherapy schedules may have a major impact on such outcomes. OBJECTIVE To evaluate preferences for oral or IV chemotherapy in patients with advanced colorectal cancer. METHODS A multicenter, randomized, crossover trial was conducted in 12 hospitals in Southern Italy, in which 22 patients with advanced colorectal cancer received one cycle of oral capecitabine ± irinotecan or oxaliplatin, followed by one cycle of an IV de Gramont or similar regimen (arm A), or the same regimens in reverse order (arm B). Patients were aged 50-70 years and 21% had a higher level of education (graduate or similar). Patients received oral capecitabine 3500 mg/m/day for 7 days (± irinotecan 180 mg/m or oxaliplatin 85 mg/m on day 1 only), followed by an IV de Gramont regimen ± irinotecan (FOLFIRI) or oxaliplatin (FOLFOX); or the two schedules administered in reverse order.The main outcome measure was patients' preferences for oral versus IV chemotherapy, as determined by a pre- and post-treatment therapy preference questionnaire (TPQ). RESULTS Before treatment, 75% of patients preferred oral therapy. Characteristics that patients considered to be important were that treatment should not interfere with daily activities (100% of patients) and should not cause fatigue (95%), diarrhea (76%), or painful mouth ulcers (76%); other factors considered important were the risk of infection and nausea (90%), and that treatment could be administered at home (65%). After receiving both chemotherapy schedules, only 45% of patients preferred oral therapy, while 55% preferred IV therapy. Among the latter, the most important characteristics influencing treatment choice were less nausea (66%), fewer mood effects (65%), the safety of hospital IV treatment (62%), less interference with family relationships (55%), less vomiting (55%), less interference with daily activities (50%), and less diarrhea (50%). Although the order in which patients received therapy did not influence treatment preference, significantly fewer patients with a lower rather than higher educational level preferred oral therapy (47% vs 80%; chi-square test = 9.9; p = 0.002). CONCLUSION These results suggest that there may be a correlation between educational level and the preference of patients with advanced colorectal cancer for oral or IV chemotherapy.
Collapse
Affiliation(s)
- Candida M Mastroianni
- 1 Mariano Santo Hospital, Cosenza, Italy 2 Siderno Hospital, Siderno, Italy 3 San Giovanni di Dio Hospital, Crotone, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Turano S, Mastroianni C, Manfredi C, Biamonte R, Ceniti S, Liguori V, De Simone R, Conforti S, Filice A, Rovito A, Viscomi C, Patitucci G, Palazzo S. Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine. J Neurooncol 2009; 98:131-5. [DOI: 10.1007/s11060-009-0052-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2009] [Accepted: 10/26/2009] [Indexed: 11/30/2022]
|
18
|
Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, Salvarani C, Buzio C. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 2005; 23:231-4. [PMID: 15895895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
OBJECTIVE Medical treatment is often effective in idiopathic retroperitoneal fibrosis (IRF) but frequently leads to residual retroperitoneal masses that may represent active disease or simply consist of inactive fibrotic tissue. 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) is a functional imaging modality that reliably assesses disease activity in a number of inflammatory diseases including IRF. We used 18F-FDG PET to evaluate the metabolic activity of residual masses in a series of IRF patients. METHODS We studied 7 consecutive IRF patients, all of whom presented constitutional symptoms and/or pain, and had high acute-phase reactant levels; 6 had ureteral involvement. IRF was diagnosed by means of computed tomography (CT), which revealed a peri-aortoiliac mass in all cases. Three patients underwent surgical ureterolysis and 2 received ureteral stents. Subsequently, 5 patients received prednisone, one sequential treatment with prednisone and tamoxifen, and one prednisolone plus methotrexate. All of the patients underwent 18F-FDG PET at varying times after the end of treatment. RESULTS The presenting signs/symptoms improved in all patients and the levels of acute-phase reactants significantly decreased or normalised. Ureteral obstructive disease resolved in all cases. Post-treatment CT revealed a considerable reduction in the amount of IRF but all of the patients had a residual retroperitoneal mass. PET revealed slight aorto-iliac 18F-FDG uptake in only one patient; all of the others were negative. No patient relapsed during the follow-up. CONCLUSIONS Post-treatment residual masses are frequent in IRF patients but, in most cases, probably represent metabolically inactive tissue.
Collapse
Affiliation(s)
- A Vaglio
- Department of Clinic al Medicine, Nephrology and Health Sciences, University of Parma, Parma, Italy
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Daniell HW, Tam E, Filice A. Larger axillary metastases in obese women and smokers with breast cancer--an influence by host factors on early tumor behavior. Breast Cancer Res Treat 1993; 25:193-201. [PMID: 8369520 DOI: 10.1007/bf00689833] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
To better define the influence by host factors on very early breast cancer behavior, we retrospectively analyzed nodal status, diameter of the largest axillary metastasis (M), diameter of the primary tumor (P), the M/P ratio, tumor estrogen receptor status, age, obesity, and smoking habits in 176 women with node-positive breast cancer. Both M/P ratios and M were larger in the 72 obese women and in the 40 nonobese smokers than in the 64 nonobese nonsmokers after control for other factors. Step-wise regression analysis demonstrated independent associations between M/P ratios and obesity (p = 0.0002), larger primary tumors (p < 0.0001), more positive nodes (p < 0.0001), and smoking (p = 0.0268), as well as between M and obesity (p = 0.0201), larger primary tumors (p = 0.0093), and more positive nodes (p = 0.0001). Among the 104 nonobese women, smoking was associated both with larger M (p = 0.0257) and larger M/P (p = 0.0055). Our observations suggest more rapid growth by metastases in obese women and smokers with breast cancer, as well as earlier metastasis from their primary tumors.
Collapse
Affiliation(s)
- H W Daniell
- Department of Family Practice, University of California Medical School, Davis
| | | | | |
Collapse
|
20
|
Filice A, Attanasio A, Capria A, Piccolo CG, Fabrizi E. [Efficacy of flecainide in the treatment of ventricular tachycardia in the elderly. Dynamic electrocardiographic study]. Clin Ter 1989; 129:459-64. [PMID: 2526707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The antiarrhythmic activity of flecainide has been tested in seven old patients (mean age 71 years) suffering from recurrent episodes of ventricular tachycardia. A basal 24-hour dynamic electrocardiogram was recorded for each patient and was repeated on day 5 of oral flecainide treatment (200 mg). A significant reduction (p less than 0.0001) of premature ventricular beats, of bigeminism (p = 0.0025) and of the episodes of ventricular tachycardia (p = 0.017) was obtained with plasma flecainide levels between 322 and 614 ng/ml. In addition, sinus rhythm was restored in two patients with stable atrial fibrillation and in the others ectopic atrial beats were markedly reduced. Among the ECG parameters examined, only QRS was significantly increased (p = 0.034). No significant change of blood pressure and laboratory parameters was observed. Untoward side effects were not observed.
Collapse
|
21
|
Filice A, Sardella F, Villanti P. [Personal experiences concerning the usefulness of the exercise test in the diagnosis of ischemic heart disease in aged patients with atypical symptomatology]. Clin Ter 1989; 129:123-7. [PMID: 2525997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Present-day therapeutic possibilities, both medical and surgical, make it mandatory for the practitioner to identify elderly patients with ischemic heart disease which in these patients often presents with atypical symptoms. Twenty elderly patients with not clear-cut symptoms of coronary disorder were submitted to an exercise test on a walking belt. In 14 (70%) the test was positive and in 8 of these 14 cases previous dynamic electrocardiography had not yielded signs of ischemia. The authors consider correctly performed exercise testing the best means for identifying the often not diagnosed coronary impairment of elderly subjects.
Collapse
|
22
|
Galante A, Lenci R, Pierangeli L, Filice A, Calcagnini G, Chessa C. [Effects of acute loading of alcohol on platelet aggregation in normal subjects]. Clin Ter 1989; 128:267-70. [PMID: 2524316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Ten healthy subjects were submitted to alcohol loading (0.8 g/kg body weight; average alcohol blood level 0.97 g 0/00). The number of platelets, hematocrit and ADP-induced platelet aggregation curves did not show any variation from baseline. Significant changes (p less than 0.05) were observed as regards latent period (increased) and maximum amplitude (reduced) for collagen-induced platelet aggregation. In agreement with others, the authors conclude that alcohol definitely inhibits platelet aggregation.
Collapse
|
23
|
Filice A, Villanti P, Sardella F. [Aneurysm of the left ventricle. Natural history and course after surgery in adult and aged patients. Review of the literature and personal experience]. Clin Ter 1988; 127:445-51. [PMID: 2977318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
24
|
Filice A, Galante A, Calcagnini G. [Surgical therapy in vascular diseases and in the acute stage of infectious endocarditis in elderly patients]. Clin Ter 1988; 127:279-84. [PMID: 2975986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
25
|
Lenci R, Galante A, Borzi M, Ariganello M, Sommariva L, Filice A, Cannata D. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients]. Clin Ter 1983; 104:205-9. [PMID: 6861457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
26
|
Peruzzi G, Tallarida G, Baldoni F, Raimondi G, Massaro M, Filice A. [Haemophilus endocarditis. A case of Haemophilus aphrophilus endocarditis in a patient with aortic and mitral valve prosthesis]. Clin Ter 1982; 102:553-74. [PMID: 6923792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
27
|
Peruzzi G, Filice A, Costa C, Palamara A. [Brucellar endocarditis. Clinical considerations]. Omnia Med Ther 1966; 44:607-18. [PMID: 5993659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
28
|
Bolognesi G, Condorelli S, Filice A, Marinoni GF, Mazzeo M, Pignataro L, Rizza O, Valora N. [Effects of the resection of various portions of the small intestine on some metabolic aspects and on the intestinal bacterial flora in the dog. II. Qualitative and quantitative study of the microbial flora]. Boll Soc Ital Biol Sper 1964; 40:322-323. [PMID: 5875790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
29
|
Bolognesi G, Condorelli S, Filice A, Marinoni GF, Mazzeo M, Pignataro L, Rizza O, Serafini NA, Valora N. [Effects of the resection of various portions of the small intestine on some metabolic aspects and on the intestinal bacterial flora of the dog. I. Variations of sideremia, of erythrocytes, of hematocrit, of protein content, of lipoprotein content, of fecal nitrogen and urinary nitrogen]. Boll Soc Ital Biol Sper 1964; 40:319-21. [PMID: 5875789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|